Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Affiliated Managers ( AMG) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock is already pricing in higher asset flows.

Apollo ( APOL) rated new Buy at Goldman. $54 price target. New enrollment declines should begin to stabilize by the August quarter.

Blackstone ( BX) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Company was also removed from the Conviction List. Valuation call.

Carefusion ( CFN) downgraded at BofA/Merrill from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $30 price target.

Columbia Sportswear ( COLM) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $70 price target. Sales outlook remains strong.

Dr. Pepper Snapple ( DPS) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. $37 price target. Company is facing higher commodity costs.

Education Management ( EDMC) downgraded at Goldman to Sell from Neutral, Goldman Sachs said. $18 price target. Company is most exposed to new regulations.

Energizer ( ENR) downgraded at UBS from Buy to Neutral, UBS said. $76 price target. Focus on Hydro razor could hurt other divisions.

Ensco ( ESV) upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. $75 price target. Stock is pricing in the recent ban in the Gulf of Mexico.

Hershey ( HSY) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Price increases should help drive earnings growth. $59 price target.

IBM ( IBM) downgraded at Canaccord from Buy to Hold, Canaccord Genuity said. Valuation call, based on a $180 price target.

Jack in the Box ( JACK) downgraded at Credit Suisse to Underperform from Neutral. Overpaying for a post-refranchising business, Credit Suisse said. Price target lowered by a dollar to $20.

Janus ( JNS) upgraded at Wells from Market Perform to Outperform. Net outflows should begin to decelerate.

Medtronic ( MDT) upgraded at Wells from Market Perform to Outperform. Growth is accelerating.

Magellan Health ( MGLN) rated new Underperform at BofA/Merrill. $50 price target. Organic growth will likely lag peers.

Monsanto ( MON) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Valuation call, based on a $78 price target.

Navistar ( NAV) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $89 price target. Company is seeing higher demand for its lower-emission truck engines.

Noble ( NE) upgraded at Morgan Stanley from Underweight to Equal-weight, Morgan Stanley said. $60 price target. Company is leveraged to rising oil prices.

National Semiconductor ( NSM) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $25 price target. See little upside potential from the NSM bid.

Rowan ( RDC) downgraded at Morgan Stanley from Overweight to Equal-weight, Morgan Stanley said. Valuation call, based on a $57 price target.

Transocean ( RIG) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $120 price target. Sector has lagged the broader market.

End of report.
This article was written by a staff member of TheStreet.

If you liked this article you might like

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

The 5 Best Dividend Aristocrats For 2018

The 5 Best Dividend Aristocrats For 2018

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

Changes to Federal Tax Law Just What the Doctor Ordered for Healthcare Firms

These Stocks Are Showing Reversal Patterns

These Stocks Are Showing Reversal Patterns